Market by Application, Reagent Type, Technology, Industry Verticals, and Country | Forecast 2021-2028
Triton’s research report has determined that the North American
sequencing reagents market is predicted to develop at a CAGR of 12.61% through
the forecasting years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries discussed in this market are:
• United States
• Canada
In North America, the United States holds the largest share in the
sequencing reagents market. This robust growth is mainly owing to the surge in
demand for gene synthetic techniques from biopharmaceutical and biotechnology
companies. Moreover, extensive research and development activities by various
research and academic institutes open new avenues for the sequencing reagents
market across the region.
In the US, the rising investments to manufacturing companies and
research institutes for developing gene synthesis-based end products, precision
medicine, and other therapeutics are driving the market’s growth. As per the
National Center for Biotechnology Information report, the government offers a
significant amount towards synthetic biology research and development each
year. Such capital investments are anticipated to support the development of
innovative products and services, contributing to the sequencing reagents
market’s growth over the estimated phase.
Furthermore, in Canada, the development of new clusters to promote the
growth of several high-tech fields is among the significant factors leading to
the development of the domestic synthetic biology segment. For instance, the
government offers significant funds every year for innovations to address the
rising challenges of creating a diverse and highly innovative economy. Other
than this, the National Research Council Canada delivers a group of DNA
synthesis and computational services to various institutes to promote genomics
growth. Hence, all these factors are creating opportunities for the sequencing
reagents market within Canada.
Agilent Technologies Inc provides instruments, software, services, and
consumable solutions to detect, analyze, and quantify products’ biological and
physical properties. The company serves various sectors, including life
science, chemical, energy, and diagnostics, among others. Additionally, it
markets its products via resellers, e-commerce platforms, distributors, and
others. Founded in 1999, Agilent is headquartered in California, the United
States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA SEQUENCING REAGENTS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. SUPPLY
CHAIN OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS
AND PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ONGOING
RESEARCH ON GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES
IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET
CHALLENGES
2.9.1. SOCIAL
AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.10. MARKET
OPPORTUNITIES
2.10.1. FUNDING
BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING
DEMAND FOR THIRD-GENERATION SEQUENCING
3. NORTH
AMERICA SEQUENCING REAGENTS MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL
INVESTIGATION
3.3. AGRI
GENOMICS AND FORENSICS
3.4. REPRODUCTIVE
HEALTH
3.5. OTHER
APPLICATIONS
4. NORTH
AMERICA SEQUENCING REAGENTS MARKET - BY REAGENT TYPE
4.1. SEQUENCING
KITS
4.2. CONTROL
KITS
4.3. LIBRARY
KITS
4.4. TEMPLATE
KITS
4.5. OTHER
REAGENT TYPES
5. NORTH
AMERICA SEQUENCING REAGENTS MARKET - BY TECHNOLOGY
5.1. NEXT-GENERATION
SEQUENCING
5.2. SANGER
SEQUENCING
5.3. THIRD-GENERATION
SEQUENCING
6. NORTH
AMERICA SEQUENCING REAGENTS MARKET - BY INDUSTRY VERTICALS
6.1. RESEARCH
INSTITUTES
6.2. HOSPITALS
AND CLINICS
6.3. PHARMACEUTICAL
AND BIOTECHNOLOGY COMPANIES
6.4. OTHER
INDUSTRY VERTICALS
7. NORTH
AMERICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY
ANALYSIS
7.1.1. UNITED
STATES
7.1.2. CANADA
8. COMPANY
PROFILE
8.1. AGILENT
TECHNOLOGIES INC
8.2. ASURAGEN
INC
8.3. BGI
GENOMICS
8.4. BIO RAD
LABORATORIES INC
8.5. F HOFFMANN
LA ROCHE
8.6. FLUIDIGM
CORPORATION
8.7. ILLUMINA
INC
8.8. LGC
BIOSEARCH TECHNOLOGIES
8.9. MERCK
KGAA
8.10. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER
INC
8.12. QIAGEN
NV
8.13. TAKARA
BIO INC
8.14. THERMO
FISHER SCIENTIFIC INC
8.15. TRILINK
BIOTECHNOLOGIES INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA SEQUENCING REAGENTS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS,
ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET,
BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET,
BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET,
BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET,
BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE
1: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
2: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE
3: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE
4: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE
5: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE
6: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
7: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE
8: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE
10: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE
11: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE
12: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE
13: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE
14: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE
15: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE
16: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE
17: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE
18: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE
19: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
20: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE
21: NORTH AMERICA SEQUENCING REAGENTS
MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE
22: UNITED STATES SEQUENCING REAGENTS
MARKET 2021-2028 (IN $ MILLION)
FIGURE
23: CANADA SEQUENCING REAGENTS MARKET
2021-2028 (IN $ MILLION)